mRNA 修饰蛋白:书写者、阅读者和擦除者。
The Proteins of mRNA Modification: Writers, Readers, and Erasers.
机构信息
Department of Biochemistry, Duke University School of Medicine, Durham, North Carolina, USA; email:
Department of Neurobiology, Duke University School of Medicine, Durham, North Carolina, USA.
出版信息
Annu Rev Biochem. 2023 Jun 20;92:145-173. doi: 10.1146/annurev-biochem-052521-035330. Epub 2023 Apr 17.
Over the past decade, mRNA modifications have emerged as important regulators of gene expression control in cells. Fueled in large part by the development of tools for detecting RNA modifications transcriptome wide, researchers have uncovered a diverse epitranscriptome that serves as an additional layer of gene regulation beyond simple RNA sequence. Here, we review the proteins that write, read, and erase these marks, with a particular focus on the most abundant internal modification, -methyladenosine (mA). We first describe the discovery of the key enzymes that deposit and remove mA and other modifications and discuss how our understanding of these proteins has shaped our views of modification dynamics. We then review current models for the function of mA reader proteins and how our knowledge of these proteins has evolved. Finally, we highlight important future directions for the field and discuss key questions that remain unanswered.
在过去的十年中,mRNA 修饰已成为细胞中基因表达调控的重要调节剂。在很大程度上,由于开发了用于检测 RNA 修饰的全转录组工具,研究人员发现了一个多样化的表观转录组,它作为除简单 RNA 序列之外的基因调控的附加层。在这里,我们综述了这些标记的写入、读取和擦除蛋白,特别关注最丰富的内部修饰,即 -甲基腺苷(mA)。我们首先描述了发现的沉积和去除 mA 和其他修饰的关键酶,并讨论了我们对这些蛋白的理解如何改变了我们对修饰动力学的看法。然后,我们综述了 mA 阅读蛋白功能的当前模型,以及我们对这些蛋白的认识是如何发展的。最后,我们强调了该领域的重要未来方向,并讨论了仍未解答的关键问题。
相似文献
Annu Rev Biochem. 2023-6-20
Nat Rev Mol Cell Biol. 2014-4-9
J Mol Endocrinol. 2023-2-1
Methods Enzymol. 2019
Trends Plant Sci. 2019-2-8
Nat Rev Mol Cell Biol. 2019-9-13
Annu Rev Cell Dev Biol. 2017-7-31
引用本文的文献
J Immunother Cancer. 2025-9-3
Front Mol Neurosci. 2025-7-1
EXCLI J. 2025-5-30
Int J Mol Sci. 2025-6-2
本文引用的文献
Cell Rep. 2022-5-24
Biomed Res Int. 2022
Mol Cell. 2022-7-7
Nucleic Acids Res. 2022-5-6
Trends Cancer. 2022-7